Loading
Life sciences · Preprint
arXiv · November 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
We introduce the Poisson Super Learner, a scalable ensemble method for survival and competing risks prediction with right-censored data. The approach exploits the correspondence between the likelihood of piecewise-constant hazard models and the Poisson likelihood. After expanding the data over a chosen time partition, candidate hazard learners are trained under a common Poisson loss, and cross-validated log-hazard predictions are combined by a Poisson meta learner. The resulting ensemble is a geometric combination of candidate hazards, and can be used to estimate survival probabilities and cause-specific absolute risks. The Poisson Super Learner framework is modular and can in principle incorporate any learner that can estimate interval-specific hazards, including parametric, penalised, additive, and other machine-learning hazard models. Training targets the cause-specific hazard directly and does not require explicit modelling of the censoring distribution. For competing risks, separate cause-specific ensembles are fitted and subsequently combined to obtain individualised cumulative incidence predictions. We illustrate the approach using data from the Steno Diabetes Center collected between 2005 and 2022 to predict cardiovascular disease risk in patients with type 1 diabetes from detailed covariate information. The applied analysis is complemented by simulation studies designed to reflect key features of the data and to examine the behaviour of the method under controlled settings. All analyses were implemented using the freely available R software package poissonsuperlearner.